CIK 0001641281
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472804636
- Phone
- +1 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- Open-market buys, last 90 days
- $628,922
- in 2 filings
- Open-market sales, last 90 days
- $128,281
- in 3 filings
Net +$500,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-12 | SHAH MAHENDRA Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2023-06-12 | SHAH MAHENDRA Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-10 | SHAH MAHENDRA Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-03-24 | SHAH MAHENDRA Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-02-09 | SHAH MAHENDRA Director | Conversion | +944,056 | 958,341 | ||
| 2021-02-09 | SHAH MAHENDRA Director | Conversion | +472,296 | 1,430,637 | ||
| 2021-02-09 | SHAH MAHENDRA Director | Option exercise | +17,711 | $0.07 | $1K | 1,448,348 |
| 2021-02-09 | SHAH MAHENDRA Director | Sale | −62 | $20.00 | $1K | 1,448,286 |
| 2021-02-09 | SHAH MAHENDRA Director | Conversion · Series A- 1 Preferred Stock | −944,056 | 0 | ||
| 2021-02-09 | SHAH MAHENDRA Director | Conversion · Series B Preferred Stock | −472,296 | 0 | ||
| 2021-02-09 | SHAH MAHENDRA Director | Option exercise · Warrant (Right to Buy) | −17,711 | 0 |
Page 1 of 1 · 11 trades